Quantitative comparative proteomics reveals candidate biomarkers for the early prediction of gestational diabetes mellitus: A preliminary study

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3021091 18 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Quantitative comparative proteomics reveals candidate biomarkers for the early prediction of gestational diabetes mellitus: A preliminary study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Aim: To identify differentially expressed proteins (DEPs) in 1st trimester maternal plasma between pregnant women at risk for gestational diabetes mellitus (GDM) and uncomplicated controls. Materials and Methods: First-trimester plasma from five women who developed GDM and five from non-diabetic ones were analyzed using isobaric tag for relative and absolute quantitation – labeled proteomics. Enzyme-linked immunosorbent assay was further applied in an independent cohort of 25 GDM cases and 25 controls for verification. Results: Prenylcysteine oxidase 1 (PCYOX1), beta-ala-his dipeptidase (CNDP1), extracellular matrix protein 1 (ECM1), basement membrane-specific heparan sulfate proteoglycan core protein (HSPG2), thrombospondin-4 (TSP-4) demonstrated significant differences in expression between the two groups (p<0.05). DEPs are mainly associated with complement and coagulation cascades. Conclusion: The reported plasma proteomic changes represent potential biomarkers for the early identification of women at risk for GDM. Future studies using larger and more diverse cohorts are necessary to assess the clinical utility of these findings. © 2020 International Institute of Anticancer Research. All rights reserved.
Έτος δημοσίευσης:
2020
Συγγραφείς:
Mavreli, D.
Evangelinakis, N.
Papantoniou, N.
Kolialexi, A.
Περιοδικό:
In vivo (Athens, Greece)
Εκδότης:
International Institute of Anticancer Research
Τόμος:
34
Αριθμός / τεύχος:
2
Σελίδες:
517-525
Λέξεις-κλειδιά:
biological marker; complement; extracellular matrix protein 1; glucose; heparan sulfate proteoglycan core protein; prenylcysteine oxidase 1; thrombospondin 4; unclassified drug; biological marker; plasma protein; proteome, adult; Article; case control study; clinical article; cohort analysis; comparative proteomics; controlled study; enzyme linked immunosorbent assay; female; gestational age; glucose blood level; high performance liquid chromatography; human; liquid chromatography-mass spectrometry; maternal age; maternal plasma; pregnancy diabetes mellitus; protein blood level; protein expression; retrospective study; biology; blood; early diagnosis; gene ontology; liquid chromatography; metabolism; pregnancy; pregnancy diabetes mellitus; procedures; prognosis; proteomics; receiver operating characteristic; tandem mass spectrometry, Adult; Biomarkers; Blood Proteins; Case-Control Studies; Chromatography, Liquid; Computational Biology; Diabetes, Gestational; Early Diagnosis; Female; Gene Ontology; Humans; Pregnancy; Prognosis; Proteome; Proteomics; ROC Curve; Tandem Mass Spectrometry
Επίσημο URL (Εκδότης):
DOI:
10.21873/invivo.11803
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.